AUTOTAC Trademark
Trademark Overview
On Wednesday, May 10, 2023, a trademark application was filed for AUTOTAC with the United States Patent and Trademark Office. The USPTO has given the AUTOTAC trademark a serial number of 97930680. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, December 2, 2024. This trademark is owned by Frontier Medicines Corporation. The AUTOTAC trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals composed of protein-, protein aggregate-, organelle- and pathogen-degrading compounds for therapeutic use in treating heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, neurodegenerative disease, neuropsychiatric disorders, cardiometabolic disease, diseases of the eye, dermatological diseases, pain, monogenic disorders, and hereditary diseases
General Information
| Serial Number | 97930680 |
| Word Mark | AUTOTAC |
| Filing Date | Wednesday, May 10, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, December 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 5, 2024 |
Trademark Statements
| Goods and Services | Pharmaceuticals composed of protein-, protein aggregate-, organelle- and pathogen-degrading compounds for therapeutic use in treating heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, cancer, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, neurodegenerative disease, neuropsychiatric disorders, cardiometabolic disease, diseases of the eye, dermatological diseases, pain, monogenic disorders, and hereditary diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 9, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Frontier Medicines Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | Frontier Medicines Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
Trademark Events
| Event Date | Event Description |
| Saturday, May 13, 2023 | NEW APPLICATION ENTERED |
| Friday, June 9, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 28, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, December 28, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, December 28, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, December 28, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, January 26, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 14, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 5, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 5, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 16, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, April 16, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 16, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 30, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, May 15, 2024 | ASSIGNED TO EXAMINER |
| Thursday, August 29, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, August 29, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 29, 2024 | SOU EXTENSION 1 FILED |
| Thursday, August 29, 2024 | SOU EXTENSION 1 GRANTED |
| Monday, December 2, 2024 | REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED |
| Monday, December 2, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, December 2, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Wednesday, January 24, 2024 | ASSIGNED TO EXAMINER |
